Breaking News Instant updates and real-time market news.

LGND

Ligand

$167.46

-2.85 (-1.67%)

, NVS

Novartis

$79.64

-2.08 (-2.55%)

10:30
04/19/18
04/19
10:30
04/19/18
10:30

H.C. Wainwright reiterates Buy on Ligand after Novartis reports Q1

H.C. Wainwright analyst Joseph Pantginis says the Promacta franchise remains strong after Ligand Pharmaceuticals (LGND) partner Novartis (NVS) reported Q1 sales Promacta revenue of $257M. The analyst projects 2018 is the year that Promacta officially reaches blockbuster status, or $1B in sales. Further, he points out that Retrophin (RTRX), another Ligand partner, earlier this month announced that the first patient has been enrolled into the Phase 3 Duplex study using sparsentan to treat patients with focal segmental glomerulosclerosis. Pantginis is encouraged by the start of the Phase 3 saying it has the potential to lock in a fixed 9% royalty to Ligand, if approved. He currently project peak sales of $825M but feels the drug could reach blockbuster status based on its first-to-market status. Pantginis keeps a Buy rating on Ligand Pharmaceuticals with a $182 price target.

LGND

Ligand

$167.46

-2.85 (-1.67%)

NVS

Novartis

$79.64

-2.08 (-2.55%)

RTRX

Retrophin

$26.71

0.26 (0.98%)

  • 19

    Apr

  • 23

    Apr

  • 01

    May

  • 03

    May

  • 10

    May

  • 17

    May

  • 21

    May

  • 29

    May

  • 05

    Jun

LGND Ligand
$167.46

-2.85 (-1.67%)

02/22/18
CHLM
02/22/18
NO CHANGE
Target $190
CHLM
Buy
Ligand price target raised to $190 from $170 at Craig-Hallum
Craig-Halluma analyst Matt Hewitt raised his price target for Ligand to $190 from $170, citing "strong" Q4 results with lots of momentum. The analyst reiterates a Buy rating on the shares.
02/26/18
ROTH
02/26/18
NO CHANGE
Target $171
ROTH
Buy
Ligand price target raised to $171 from $158 at Roth Capital
Roth Capital analyst Scott Henry raised his price for Ligand to $171 from $158 after the company reported Q4 results and set guidance for 2018. The analyst expects royalty numbers to beat company targets, and believes about $20M in potentially known milestones could add 60c to EPS and milestones related to future partnering deals could add even more upside. He reiterates a Buy rating on the shares.
03/07/18
CHLM
03/07/18
NO CHANGE
Target $200
CHLM
Buy
Ligand price target raised to $200 from $190 at Craig-Hallum
Craig-Hallum analyst Matt Hewitt raised his price target for Ligand to $200 from $190 after the long-awaited GRA Program licensing agreement was signed. The analyst sees the terms as favorable for the company and reiterates a Buy rating on the shares.
03/07/18
HCWC
03/07/18
NO CHANGE
Target $182
HCWC
Buy
Ligand price target raised to $182 from $170 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for Ligand Pharmaceuticals to $182 after the company announced a global partnership for LGD-6972. The company's strategic decision to navigate LGD-6972 through Phase 2 paid off, Pantginis tells investors in a research note. He keeps a Buy rating on the shares.
NVS Novartis
$79.64

-2.08 (-2.55%)

04/16/18
ROTH
04/16/18
NO CHANGE
Target $27
ROTH
Buy
CymaBay seladelpar a 'clear winner' from EASL, says Roth Capital
Roth Capital analyst Yasmeen Rahimi notes that Novartis (NVS) reported disappointing 28-day interim results from its FXR agonist in 49 PBC patients at EASL. Tropifexor had AP level drops far below CymaBay's (CBAY) seldelpar at 4 weeks, she points out, adding that she believes seladelpar is a "clear winner" from Paris. Rahimi reiterates a Buy rating and $27 price target on CymaBay's shares.
04/18/18
JEFF
04/18/18
DOWNGRADE
Target $218
JEFF
Hold
AveXis downgraded to Hold from Buy at Jefferies
Jefferies analyst Biren Amin downgraded AveXis (AVXS) to Hold while raising his price target for the shares to $218 from $141. The analyst's downgrade and new price target reflect the pending acquisition by Novartis (NVS).
04/18/18
BERN
04/18/18
NO CHANGE
BERN
Spark Therapeutics, uniQure may be potential takeout targets, says Bernstein
Following AveXis (AVXS) acquisition by Novartis (NVS), Bernstein analyst Vincent Chen says the potential next target should have a strong portfolio fit and innovation-oriented scientifically-minded management teams likely comfortable with the technology platform. For acquisition targets, the analyst sees two flavors, namely late stage more de-risked gene therapy companies, for which Spark (ONCE) comes to mind, and less costly but riskier earlier-stage platforms, for which uniQure (QURE), Voyager (VYGR) and REGENXBIO (RGNX) come to mind.
04/19/18
WELS
04/19/18
NO CHANGE
WELS
Wells says bottom has not been reached in generics pricing
After Aceto (ACET) cited the continued intense competitive and pricing pressures in the generic industry when withdrawing its guidance last night, and Novartis (NVS) this morning reported that net sales at its generic unit Sandoz dropped 4% in the quarter, Wells Fargo analyst Davis Maris says he's not ready to call the bottom in generics pricing. Those that have are premature, Maris tells investors in a research note titled "Negative Read Throughs For Generics Continue." The Aceto and Sandoz pricing news shows the data continue to be negative for U.S. generic industry pricing, the analyst contends. He sees a negative read-through for companies with large U.S. commodity generic exposure, such as Teva (TEVA) and Mylan (MYL).
RTRX Retrophin
$26.71

0.26 (0.98%)

TODAY'S FREE FLY STORIES

VSAT

ViaSat

$61.75

-1.08 (-1.72%)

09:03
05/25/18
05/25
09:03
05/25/18
09:03
Recommendations
ViaSat analyst commentary  »

ViaSat price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$64.15

-0.02 (-0.03%)

09:02
05/25/18
05/25
09:02
05/25/18
09:02
Recommendations
Carnival analyst commentary  »

Carnival capacity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

GVA

Granite Construction

$57.18

-0.48 (-0.83%)

09:01
05/25/18
05/25
09:01
05/25/18
09:01
Recommendations
Granite Construction analyst commentary  »

Granite Construction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$22.26

-0.205 (-0.91%)

08:58
05/25/18
05/25
08:58
05/25/18
08:58
Technical Analysis
Technical Take: Fiat Chrysler falls on 4.8M vehicle U.S.-market recall »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKE

The Buckle

$25.75

0.65 (2.59%)

08:55
05/25/18
05/25
08:55
05/25/18
08:55
Technical Analysis
Technical Take: The Buckle slides lower after reporting earnings »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

BAC

Bank of America

$30.19

-0.26 (-0.85%)

, PBR

Petrobras

$12.77

-2.335 (-15.46%)

08:55
05/25/18
05/25
08:55
05/25/18
08:55
Options
Notable open interest changes for May 25th »

Thursday's total…

BAC

Bank of America

$30.19

-0.26 (-0.85%)

PBR

Petrobras

$12.77

-2.335 (-15.46%)

AAPL

Apple

$188.18

-0.18 (-0.10%)

AFSI

AmTrust

$13.73

-0.045 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

ROST

Ross Stores

$82.95

0.35 (0.42%)

08:52
05/25/18
05/25
08:52
05/25/18
08:52
Technical Analysis
Technical Take: Ross Stores falls after earnings »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$32.97

1 (3.13%)

, FL

Foot Locker

$46.38

1.35 (3.00%)

08:52
05/25/18
05/25
08:52
05/25/18
08:52
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Amarin (AMRN), up…

GPS

Gap

$32.97

1 (3.13%)

FL

Foot Locker

$46.38

1.35 (3.00%)

DECK

Deckers Brands

$103.63

0.8 (0.78%)

HIBB

Hibbett Sports

$28.95

0.6 (2.12%)

AMRN

Amarin

$3.04

0.04 (1.33%)

TEVA

Teva

$21.64

0.485 (2.29%)

BMRN

BioMarin

$88.30

-0.2 (-0.23%)

ZOES

Zoe's Kitchen

$14.48

-0.41 (-2.75%)

EGHT

8x8, Inc.

$22.00

0.35 (1.62%)

ADSK

Autodesk

$138.76

-0.54 (-0.39%)

SPLK

Splunk

$116.35

-0.2 (-0.17%)

CBB

Cincinnati Bell

$15.93

-0.225 (-1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 25

    May

  • 25

    May

  • 29

    May

  • 05

    Jun

  • 05

    Jun

  • 12

    Jun

  • 14

    Jun

  • 16

    Jun

  • 10

    Jul

  • 12

    Sep

LOMA

Loma Negra

$11.52

-1.47 (-11.32%)

08:51
05/25/18
05/25
08:51
05/25/18
08:51
Upgrade
Loma Negra rating change  »

Loma Negra upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOMA

Loma Negra

$11.52

-1.47 (-11.32%)

08:50
05/25/18
05/25
08:50
05/25/18
08:50
Hot Stocks
Loma Negra says not under investigation in Argentina for cartelization »

Loma Negra said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$272.87

-0.5 (-0.18%)

, SPX

S&P 500

$0.00

(0.00%)

08:49
05/25/18
05/25
08:49
05/25/18
08:49
General news
Trump says 'time will tell' after 'warm and productive' North Korean statement »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$272.87

-0.5 (-0.18%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLF

Herbalife Nutrition

$53.85

-0.14 (-0.26%)

08:47
05/25/18
05/25
08:47
05/25/18
08:47
Hot Stocks
Herbalife Nutrition announces preliminary results of self-tender offer »

Herbalife Nutrition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$22.26

-0.205 (-0.91%)

08:46
05/25/18
05/25
08:46
05/25/18
08:46
Hot Stocks
Fiat Chrysler recalls estimated 4.8M U.S.-market vehicles for software upgrade »

FCA US announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:45
05/25/18
05/25
08:45
05/25/18
08:45
Conference/Events
Federal Reserve Chairman Powell participates in a panel discussion »

Federal Reserve Chairman…

NOK

Nokia

$6.09

-0.01 (-0.16%)

, AAOI

Applied Optoelectronics

$33.91

0.24 (0.71%)

08:45
05/25/18
05/25
08:45
05/25/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

NOK

Nokia

$6.09

-0.01 (-0.16%)

AAOI

Applied Optoelectronics

$33.91

0.24 (0.71%)

MDXG

MiMedx

$8.86

-0.12 (-1.34%)

GERN

Geron

$4.81

0.14 (3.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

08:45
05/25/18
05/25
08:45
05/25/18
08:45
General news
Treasury Action: yields remained at low ebb »

Treasury Action: yields…

08:35
05/25/18
05/25
08:35
05/25/18
08:35
General news
U.S. durable goods orders fell 1.7% in April »

U.S. durable goods orders…

TIF

Tiffany

$126.44

0.3 (0.24%)

08:34
05/25/18
05/25
08:34
05/25/18
08:34
Recommendations
Tiffany analyst commentary  »

Tiffany price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

DECK

Deckers Brands

$103.63

0.8 (0.78%)

08:34
05/25/18
05/25
08:34
05/25/18
08:34
Technical Analysis
Technical Take: Deckers at new 52-week high after earnings, analyst action »

The company reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USNA

USANA

$116.75

-2.85 (-2.38%)

08:34
05/25/18
05/25
08:34
05/25/18
08:34
Hot Stocks
USANA clinical sciences team to be led by Rolando Maddela, Jessie Johnson »

USANA is announcing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$102.36

-1.08 (-1.04%)

08:33
05/25/18
05/25
08:33
05/25/18
08:33
Recommendations
Weibo analyst commentary  »

Weibo risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

HWC

Hancock Whitney Corporation

$51.60

-0.2 (-0.39%)

, BBRG

Bravo Brio Restaurant

$4.05

(0.00%)

08:30
05/25/18
05/25
08:30
05/25/18
08:30
Options
One new option listing and two option delistings on May 25th »

New option listings for…

HWC

Hancock Whitney Corporation

$51.60

-0.2 (-0.39%)

BBRG

Bravo Brio Restaurant

$4.05

(0.00%)

HBHC

Symbol changed to HWC

$51.60

-0.2 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:30
05/25/18
05/25
08:30
05/25/18
08:30
General news
Fed Chairman Powell will make an appearance »

Fed Chairman Powell will…

SPLK

Splunk

$116.35

-0.2 (-0.17%)

08:28
05/25/18
05/25
08:28
05/25/18
08:28
Recommendations
Splunk analyst commentary  »

Splunk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

FL

Foot Locker

$46.38

1.35 (3.00%)

08:27
05/25/18
05/25
08:27
05/25/18
08:27
Technical Analysis
Technical Take: Foot Locker sharply higher after earning beat, outlook »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.